stella
beta
Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer — Stella
Recruiting
Back to Cervical Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Recruiting
View full record on ClinicalTrials.gov